Psychiatry and Neurology, Neurology · Nashville, TN
NPI
1588059869
Since 2015
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 936-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
405 services
Medicare patients, 2024
156
Average age 72
Drug cost, 2024
$2.1M
1,698 prescriptions
Company payments, 2025
$599
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy E Brown was code 99214 (office e&m - established), 149 times for 94 patients. In total Amy E Brown billed 405 services in 27 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 149 | 94 | $65.87 | $9,814 |
| 99215 Office E&M - Established | Facility | 45 | 39 | $102.76 | $4,624 |
| 95983 Electrical Nerve Conductivity | Facility | 33 | 22 | $32.15 | $1,061 |
| 99213 Office E&M - Established | Facility | 20 | 17 | $33.30 | $666 |
| 99214 Office E&M - Established | Office | 19 | 15 | $80.35 | $1,527 |
| 95970 Electrical Nerve Conductivity | Facility | 15 | 12 | $12.25 | $184 |
By year: 2022 $38K for 564 services; 2023 $26K for 432 services; 2024 $27K for 405 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy E Brown prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 209 prescriptions and refills. In total Amy E Brown wrote 1,698 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 209 | 481 | 73 | $10K |
| Clonazepam Generic | 126 | 132 | 21 | $1,774 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 91 | 201 | 35 | $6,526 |
| Austedo Xr Deutetrabenazine | 77 | 77 | Under 11 | $889K |
| Gocovri Amantadine Hcl | 75 | 77 | 16 | $199K |
| Amantadine Amantadine Hcl | 70 | 168 | 24 | $4,294 |
| Gabapentin Generic | 64 | 108 | 19 | $1,368 |
| Quetiapine Fumarate Generic | 52 | 104 | 14 | $809 |
| Baclofen Generic | 50 | 110 | 18 | $756 |
| Nuplazid Pimavanserin Tartrate | 45 | 45 | Under 11 | $215K |
| Nourianz Istradefylline | 40 | 40 | Under 11 | $72K |
| Clozapine Generic | 32 | 32 | Under 11 | $290 |
| Austedo Deutetrabenazine | 30 | 30 | Under 11 | $149K |
| Sertraline Hcl Generic | 30 | 82 | 13 | $356 |
| Donepezil Hcl Generic | 30 | 62 | Under 11 | $358 |
Brand drugs: 410 claims; generic drugs: 1,288 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy E Brown $599 ($599 in general payments such as food, travel and fees) from 5 companies. The largest payer was Neurocrine BioSciences, Inc. with $422.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.